(September 2019) “Oncolytic Measles Virotherapy and Opposition to Measles Vaccination.”, Mayo Clinic Proceedings (en) 94 (9), p. 1834–39. doi:10.1016/j.mayocp.2019.05.006.
(August 2013) “Antibiotics for preventing complications in children with measles”, The Cochrane Database of Systematic Reviews (en) 8 (8), p. CD001477. doi:10.1002/14651858.CD001477.pub4.
(October 2016) “Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015”, Lancet (en) 388 (10053), p. 1459–1544. doi:10.1016/S0140-6736(16)31012-1.
(January 2015) “Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013”, Lancet (en) 385 (9963), p. 117–71. doi:10.1016/S0140-6736(14)61682-2.
merckmanuals.com
Caserta, MT: Measles (angle). Merck Sharp & Dohme Corp. (September 2013). Arkivita el la originalo je 23 March 2014. Alirita 23 March 2014.
